A comparison of vitamin D activity in paired non-malignant and malignant human breast tissues

被引:12
|
作者
Suetani, Rachel J. [1 ]
Ho, Kristen [1 ]
Jindal, Shalini [2 ]
Manavis, Jim [3 ]
Neilsen, Paul M. [1 ]
Pishas, Kathleen I. [1 ]
Rippy, Elisabeth [5 ]
Bochner, Melissa [5 ]
Kollias, James [5 ]
Gill, P. Grantley [5 ]
Morris, Howard A. [4 ]
Callen, David F. [1 ]
机构
[1] Univ Adelaide, Ctr Personalised Canc Med, Breast Canc Genet Grp, Adelaide, SA 5005, Australia
[2] Univ Adelaide, Discipline Med, Dame Roma Mitchell Canc Res Lab, Adelaide, SA 5005, Australia
[3] SA Pathol, Ctr Neurol Dis, Adelaide, SA, Australia
[4] SA Pathol, Endocrine Bone Res Lab, Adelaide, SA, Australia
[5] Royal Adelaide Hosp, Breast Endocrine & Surg Oncol Unit, Adelaide, SA, Australia
基金
英国医学研究理事会;
关键词
Breast cancer; 1,25-Dihydroxyvitamin D; 25-Hydroxyvitamin D; Ex vivo breast tissue; D-RECEPTOR; D PATHWAY; CANCER; EXPRESSION; D-3; GROWTH; CELLS; METABOLISM; CYP27B1; RISK;
D O I
10.1016/j.mce.2012.06.022
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Links between a low vitamin D status and an increased risk of breast cancer have been observed in epidemiological studies. These links have been investigated in human tissue homogenates and cultured cell lines. We have used non-malignant, malignant and normal reduction mammoplasty breast tissues to investigate the biological and metabolic consequences of the application of vitamin D to intact ex vivo human breast tissue. Tissues were exposed to 1 alpha,25(OH)(2)D-3 (1,250; active metabolite) and 25(OH)D (25D; pre-metabolite). Changes in mRNA expression and protein expression after vitamin D exposure were analysed. Results indicate that while responses in normal and non-malignant breast tissues are similar between individuals, different tumour tissues are highly variable with regards to their gene expression and biological response. Collectively, malignant breast tissue responds well to active 1,25D, but not to the inactive pre-metabolite 25D. This may have consequences for the recommendation of vitamin D supplementation in breast cancer patients. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:202 / 210
页数:9
相关论文
共 50 条
  • [31] Effect of microbial siderophores on mammalian non-malignant and malignant cell lines
    Gokarn, Karuna
    Sarangdhar, Vishwas
    Pal, Ramprasad B.
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2017, 17
  • [32] Effects of the exercise-inducible myokine irisin on malignant and non-malignant breast epithelial cell behavior in vitro
    Gannon, Nicholas P.
    Vaughan, Roger A.
    Garcia-Smith, Randi
    Bisoffi, Marco
    Trujillo, Kristina A.
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (04) : E197 - E202
  • [33] The prevalence of malignant neoplastic and non-malignant gastrointestinal lesions in cardiology inpatients
    Sakamoto, Aiko
    Fujishiro, Mitsuhiro
    Koike, Kazuhiko
    Nagai, Ryozo
    Ishizaka, Nobukazu
    JOURNAL OF CARDIOLOGY, 2013, 61 (1-2) : 181 - 185
  • [34] Expression of Prostaglandin- and Vitamin D-metabolising Enzymes in Benign and Malignant Breast Cells
    Thill, Marc
    Hoellen, Frederike
    Becker, Steffi
    Dittmer, Christine
    Fischer, Dorothea
    Kuemmel, Sherko
    Salehin, Darius
    Friedrich, Michael
    Koester, Frank
    Diedrich, Klaus
    Cordes, Tim
    ANTICANCER RESEARCH, 2012, 32 (01) : 367 - 372
  • [35] Expression of 11β-hydroxysteroid Dehydrogenase Type 1 in Breast Cancer and Adjacent Non-Malignant Tissue. An Immunocytochemical Study
    Lu, Lu
    Zhao, Gang
    Luu-The, Van
    Ouellet, Johanne
    Fan, Zhinmin
    Labrie, Fernand
    Pelletier, Georges
    PATHOLOGY & ONCOLOGY RESEARCH, 2011, 17 (03) : 627 - 632
  • [36] Anticancer Activity of Vitamin D, Lumisterol and Selected Derivatives against Human Malignant Melanoma Cell Lines
    Domzalski, Pawel
    Piotrowska, Anna
    Tuckey, Robert C.
    Zmijewski, Michal A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (20)
  • [37] Diagnostic yield of bronchoalveolar lavage in immunocompromised children with malignant and non-malignant disorders
    Nadimpalli, Sruti
    Foca, Marc
    Satwani, Prakash
    Sulis, Maria Luisa
    Constantinescu, Andrei
    Saiman, Lisa
    PEDIATRIC PULMONOLOGY, 2017, 52 (06) : 820 - 826
  • [38] Symptom burden in malignant and non-malignant disease on admission to a palliative care unit
    See, David
    Le, Brian
    Gorelik, Alexandra
    Eastman, Peter
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2022, 12 (E6) : E792 - E797
  • [39] Breakthrough pain in malignant and non-malignant diseases:: a review of prevalence, characteristics and mechanisms
    Svendsen, KB
    Andersen, S
    Arnason, S
    Arnér, S
    Breivik, H
    Heiskanen, T
    Kalso, E
    Kongsgaard, UE
    Sjogren, P
    Strang, P
    Bach, FW
    Jensen, TS
    EUROPEAN JOURNAL OF PAIN, 2005, 9 (02) : 195 - 206
  • [40] The effects of erythropoietin signaling on telomerase regulation in non-erythroid malignant and non-malignant cells
    Uziel, Orit
    Kanfer, Gil
    Beery, Einat
    Yelin, Dana
    Shepshelovich, Daniel
    Bakhanashvili, Mary
    Nordenberg, Jardena
    Lahav, Meir
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 450 (01) : 274 - 282